Literature DB >> 19197093

The incidence of deep venous thrombosis in Chinese medical Intensive Care Unit patients.

Gavin M Joynt1, Thomas S T Li, James F Griffith, Charles D Gomersall, Florence H Y Yap, Anthony M H Ho, Patricia Leung.   

Abstract

OBJECTIVE: To evaluate the incidence of deep venous thrombosis in critically ill, Intensive Care Unit patients of Chinese ethnicity.
DESIGN: Prospective, observational study.
SETTING: Intensive Care Unit in a Hong Kong teaching hospital. PATIENTS: Consecutive adult Chinese medical patients not receiving pharmacological or mechanical prophylaxis for deep venous thrombosis. MAIN OUTCOME MEASURES: Compression and duplex Doppler ultrasound examinations of the lower limbs within 24 hours of admission and twice weekly thereafter during their Intensive Care Unit stay. After discharge, a 1-week follow-up investigation was also performed. Demographic data and risk factors for deep venous thrombosis were prospectively recorded.
RESULTS: Over a 9-month study period, 80 patients were investigated. Deep venous thrombosis was detected by ultrasound examination in 15 (19%) of the patients (95% confidence interval, 14-23%). Nine of 15 had isolated below-knee deep venous thrombosis, and of these, five had bilateral involvement. Characteristics of patients with or without deep venous thrombosis were similar. Of the 15 patients who had a positive ultrasound examination, only four (27%) had clinical signs of deep venous thrombosis. Of the 65 patients without a positive ultrasound examination, only two (3%) had positive clinical signs (P=0.01). This yielded a moderate positive likelihood ratio of 9 (95% confidence interval, 2-43) and a small negative likelihood ratio of 0.76 (95% confidence interval, 0.56-1.03). There were no cases of pulmonary embolism. Hospital mortality in those with and without deep venous thrombosis was 33% and 28%, respectively.
CONCLUSIONS: In the absence of prophylaxis, the incidence of deep venous thrombosis in Chinese medical Intensive Care Unit patients is lower than that reported in similar Caucasian patients, but higher than expected. As clinical features are not able to reliably exclude the presence of deep venous thrombosis, early routine prophylaxis for deep venous thrombosis in Chinese medical Intensive Care Unit patients should be considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197093

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  9 in total

Review 1.  The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.

Authors:  Alessandra Malato; Francesco Dentali; Sergio Siragusa; Francesco Fabbiano; Yoan Kagoma; Maria Boddi; Gian Franco Gensini; Adriano Peris; Mark Crowther; Mariasanta Napolitano
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

2.  Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study.

Authors:  Celine Sze Ling Chui; Min Fan; Eric Yuk Fai Wan; Miriam Tim Yin Leung; Edmund Cheung; Vincent Ka Chun Yan; Le Gao; Yonas Ghebremichael-Weldeselassie; Kenneth K C Man; Kui Kai Lau; Ivan Chun Hang Lam; Francisco Tsz Tsun Lai; Xue Li; Carlos King Ho Wong; Esther W Chan; Ching-Lung Cheung; Chor-Wing Sing; Cheuk Kwong Lee; Ivan Fan Ngai Hung; Chak Sing Lau; Joseph Yat Sun Chan; Michael Kang-Yin Lee; Vincent Chung Tong Mok; Chung-Wah Siu; Lot Sze Tao Chan; Terence Cheung; Frank Ling Fung Chan; Anskar Yu-Hung Leung; Benjamin John Cowling; Gabriel Matthew Leung; Ian Chi Kei Wong
Journal:  EClinicalMedicine       Date:  2022-06-25

Review 3.  A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.

Authors:  Kai Chin Poh; Victoria Yu Jia Tay; Sarah Huixin Lin; Huei Leng Chee; Suhitharan Thangavelautham
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

4.  Perspective on the hospital incidence rate of deep venous coagulopathy: Clinical and biochemical diagnostic markers.

Authors:  Alireza Khosravi; Mojgan Gharipour; Morteza Abdar Isfahani; Hamid Mohajeri; Mohammad Saadatnia; Farshad Roghani; Shahin Shirani; Arsalan Khaledifar
Journal:  Adv Biomed Res       Date:  2014-12-12

5.  Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures.

Authors:  Kitchai Luksameearunothai; Paphon Sa-Ngasoongsong; Noratep Kulachote; Sorawut Thamyongkit; Praman Fuangfa; Pongsthorn Chanplakorn; Patarawan Woratanarat; Chanyut Suphachatwong
Journal:  BMC Musculoskelet Disord       Date:  2017-05-22       Impact factor: 2.362

6.  Incidence of proximal deep vein thrombosis in medical critical care patients.

Authors:  Chairat Permpikul; Walailak Chaiyasoot; Anupol Panitchote
Journal:  Thromb J       Date:  2022-02-05

7.  Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.

Authors:  Li Li; Jia Zhou; Liquan Huang; Junhai Zhen; Lina Yao; Lingen Xu; Weimin Zhang; Gensheng Zhang; Qijiang Chen; Bihuan Cheng; Shijin Gong; Guolong Cai; Ronglin Jiang; Jing Yan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Deep Vein Thrombosis among Intensive Care Unit Patients; an Epidemiologic Study.

Authors:  MirMohammad Miri; Reza Goharani; Mohammad Sistanizad
Journal:  Emerg (Tehran)       Date:  2017-01-09

9.  Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China.

Authors:  Li Yang; Jingjing Wu
Journal:  BMJ Open       Date:  2020-07-30       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.